Evidence map›Paper›PMID 8288316›Full record

ArticleImmunology1993

Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin.

M R Young, J L Kut, M P Coogan, M A Wright, M E Young, J Matthews

Open access · greenAbstract read
In one paragraph

Article in Immunology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. The Effects of Serotonin in Immune Cells.Frontiers in cardiovascular medicine · 2017
    Review
  9. Article
  10. Review
  11. Immunomodulatory effects mediated by serotonin.Journal of immunology research · 2015
    Review
  12. Article
  13. Serotonin paracrine signaling in tissue fibrosis.Biochimica et biophysica acta · 2013
    Review
  14. Review
  15. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Hyperserotoninemia and altered immunity in autism.Journal of autism and developmental disorders · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M R YoungResearch Service, Hines V.A. Hospital, Hines, IL 60141.
J L Kut
M P Coogan
M A Wright
M E Young
J Matthews
Edward Hines, Jr. VA Hospital · US

Funding

PROTEIN PHOSPHATASES-1 AND-2A RESTRICT TUMOR METASTASISR01CA045080 · NCI · LOYOLA UNIVERSITY CHICAGO · PI YOUNG, M. RITA · 1986 to 2001
$389k
MYELOID DIFFERENTIATION THERAPY TO AUGMENT IMMUNOTHERAPYR01CA048080 · NCI · LOYOLA UNIVERSITY CHICAGO · PI YOUNG, M. RITA · 1990 to 1997
–
NCI NIH HHS CA-45080NCI NIH HHS CA-48080
6 · The paper itself

Abstract

The modulatory effects of endogenous serotonin on splenic T-cell activity were investigated using two distinct approaches. The first approach showed that pretreatment of mice with p-cholorphenylalanine (PCPA) to deplete intracellular stores of serotonin reduced the capacity of their splenic T cells to proliferate and to express interleukin-2 receptor (IL-2R) in response to concanavalin A (Con A). These responses could be restored by the addition of serotonin to the spleen cell cultures. In contrast, PCPA treatment did not effect stimulation of spleen cells to produce IL-2. The second approach showed that T-cell proliferation to Con A as well as to IL-2 was diminished by the presence of antagonists to the serotonin-2 receptor (5-HT2R). The effects of low doses (100 ng/ml) of exogenously added serotonin on functions of normal spleen cells were also examined. At this low dose, serotonin stimulated splenic T-cell proliferation in response to IL-2, and enhanced both proliferation and IL-2 production in response to a suboptimal concentration of Con A. These results show autologous serotonin to be required for T-cell activation and that the activation of suboptimally stimulated T cells can be augmented with low doses of exogenously added serotonin. These data also suggest that the positive regulation of T-cell function by serotonin is mediated through 5-HT2R.

Indexed as

AnimalsCell DivisionCells, CulturedFenclonineInterleukin-2Lymphocyte ActivationMaleMiceMice, Inbred C57BLReceptors, Interleukin-2SerotoninSerotonin AntagonistsSpleenT-LymphocytesFenclonineInterleukin-2Receptors, Interleukin-2SerotoninSerotonin Antagonists

Identifiers

PMID8288316
PMCPMC1422219
OpenAlexW157700787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.